SCHEMBL3358883

SCHEMBL3358883

Cn1cc(CN2CCOCC2)c2cc([N+](=O)[O-])ccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSB P07858 1/20 0.59
ALDH1A1 P00352 4/20 0.52
MAPT P10636 3/20 0.52
KCNJ1 P48048 3/20 0.52
LMNA P02545 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HTR6 P50406 1/20 0.50
CACNB4 O00305 1/20 0.48
CACNA1A O00555 1/20 0.48
CACNA1G O43497 1/20 0.48
CACNG3 O60359 1/20 0.48
CACNA1F O60840 1/20 0.48
CACNA1H O95180 1/20 0.48
CACNB3 P54284 1/20 0.48
CACNA2D1 P54289 1/20 0.48
CACNG7 P62955 1/20 0.48
CACNA1B Q00975 1/20 0.48
CACNA1D Q01668 1/20 0.48
CACNB1 Q02641 1/20 0.48
CACNG1 Q06432 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3357652 0.91 CTSB (0.59) CTSBALDH1A1MAPTKCNJ1LMNA
SCHEMBL3352554 0.89 KMT2A (0.51) CTSBALDH1A1MAPTKCNJ1LMNA
SCHEMBL3352978 0.89 CACNB4 (0.56) CTSBALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL13537253 0.88 HRH3 (0.48) CTSBALDH1A1MAPTKCNJ1LMNA
SCHEMBL3353450 0.88 HTR6 (0.62) ALDH1A1LMNAHTR6CACNB4CACNA1A
SCHEMBL3356257 0.88 CACNB4 (0.58) CTSBALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL3357604 0.87 CTSB (0.56) CTSBALDH1A1MAPTKCNJ1LMNA
SCHEMBL9400557 0.79 MAPT (0.51) MAPTLMNASMN1; SMN2KMT2APOLB
SCHEMBL3357664 0.79 HRH3 (0.47) ALDH1A1MAPTLMNAHRH3
SCHEMBL29215987 0.79 HRH3 (0.47) LMNAHTR6HRH3CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed